Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zepp Health (ZEPP) Minority Interest (2017 - 2024)

Historic Minority Interest for Zepp Health (ZEPP) over the last 7 years, with Q4 2024 value amounting to $1.1 million.

  • Zepp Health's Minority Interest fell 3128.13% to $1.1 million in Q4 2024 from the same period last year, while for Dec 2024 it was $1.1 million, marking a year-over-year decrease of 3128.13%. This contributed to the annual value of $1.1 million for FY2024, which is 3912.35% down from last year.
  • Latest data reveals that Zepp Health reported Minority Interest of $1.1 million as of Q4 2024, which was down 3128.13% from $1.7 million recorded in Q4 2023.
  • Zepp Health's 5-year Minority Interest high stood at $2.0 million for Q4 2021, and its period low was $1.1 million during Q4 2024.
  • Moreover, its 4-year median value for Minority Interest was $1.7 million (2022), whereas its average is $1.6 million.
  • As far as peak fluctuations go, Zepp Health's Minority Interest tumbled by 492.55% in 2023, and later tumbled by 3128.13% in 2024.
  • Quarter analysis of 4 years shows Zepp Health's Minority Interest stood at $2.0 million in 2021, then dropped by 14.86% to $1.7 million in 2022, then decreased by 4.93% to $1.7 million in 2023, then crashed by 31.28% to $1.1 million in 2024.
  • Its Minority Interest stands at $1.1 million for Q4 2024, versus $1.7 million for Q4 2023 and $1.7 million for Q4 2022.